1 research outputs found
Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for <sup>64</sup>Cu Radiotracers
Bifunctional chelators have been
successfully used to construct <sup>64</sup>Cu-labeled radiopharmaceuticals.
Previously reported chelators with cross-bridged cyclam backbones
have various essential features such as high stability of the copperÂ(II)
complex, high efficiency of radiolabeling at room temperature, and
good biological inertness of the radiolabeled complex, along with
rapid body clearance. Here, we report a new generation propylene-cross-bridged
chelator with hybrid acetate/phosphonate pendant groups (PCB-TE1A1P)
developed with the aim of combining these key properties in a single
chelator. The PCB-TE1A1P was synthesized from cyclam with good overall
yield. The CuÂ(II) complex of our chelator showed good robustness in
kinetic stability evaluation experiments, such as acidic decomplexation
and cyclic voltammetry studies. The CuÂ(II) complex of PCB-TE1A1P remained
intact under highly acidic conditions (12 M HCl, 90 °C) for 8
d and showed quasi-reversible reduction/oxidation peaks at −0.77
V in electrochemical studies. PCB-TE1A1P was successfully radiolabeled
with <sup>64</sup>Cu ions in an acetate buffer at 60 °C within
60 min. The electrophoresis study revealed that the <sup>64</sup>Cu-PCB-TE1A1P
complex has net negative charge in aqueous solution. The biodistribution
and in vivo stability study profiles of <sup>64</sup>Cu-PCB-TE1A1P
indicated that the radioactive complex was stable under physiological
conditions and cleared rapidly from the body. A whole body positron
emission tomography (PET) imaging study further confirmed high in
vivo stability and fast clearance of the complex in mouse models.
In conclusion, PCB-TE1A1P has good potential as a bifunctional chelator
for <sup>64</sup>Cu-based radiopharmaceuticals, especially those involving
peptides